• News
    • Pharma News
    • Healthcare
    • Marketing
    • Opinion
    • In Depth
    • Spotlight: Advertorial from Pf Partners
    • Careers
    • Mergers & acquisitions
  • COVID-19
  • PharmaJobs
    • Find a job
    • Career advice
    • Graduates
  • Pf Magazine
  • Pf Informs
  • Pf Awards
  • About
    • About Pf
    • Advertise
    • Submissions
    • Contact
  • Subscribe
Search
  • Subscribe
  • About
  • Advertise
  • Submissions
  • Contact
Pharmafield
  • News
    • Pharma News
    • Healthcare
    • Marketing
    • Opinion
    • In Depth
    • Spotlight: Advertorial from Pf Partners
    • Careers
    • Mergers & acquisitions
  • COVID-19
  • PharmaJobs
    • Find a job
    • Career advice
    • Graduates
  • Pf Magazine
  • Pf Informs
  • Pf Awards
  • About
    • About Pf
    • Advertise
    • Submissions
    • Contact
  • Subscribe
  • In Depth

Coffee break with… Caroline Armstrong

By
Pharmafield
-
November 21, 2012
Facebook
Twitter
Linkedin
Email
    pharmafield logo - pharma news

    John Pinching meets Novartis’ Senior Brand Manager, Caroline Armstrong. 

    What is your background, Caroline? I come from Newcastle and did a degree in Biomedical Science at the University of Newcastle Upon Tyne. During my time there I worked in a lab at Proctor and Gamble. After approximately five minutes I knew it wasn’t the career for me! I needed to do more than just take microscope slides out of a washing machine for the rest of my life.

    How did you embark on a career in the selling side of pharmaceutical drugs?
    I attended a recruitment drive, was impressed with the potential opportunities and became a medical sales representative, first at AmDel, then Altana Pharma. I know it’s a cliché, but in order to fulfil my ambitions I had to be out there, ‘carrying the bag’; it’s the best way to build a network and discover how the industry really works.

    Do you remember your first gig? Yes, it was pretty nerve-wracking. As soon as I arrived at the surgery, I was taken straight to the GP, without any time to compose myself. It was a steep learning curve, but I soon gained confidence and was able to apply my personality when describing products. Showing your human side in medical sales is vital.

    How did that enable you to progress further? I joined Novartis initially as a Vaccine Account Manager, before getting the chance to go on a marketing secondment. I really felt like the company believed in my ability and this ultimately led to my roles as the UK Influenza Brand Manager and Travel Vaccines Senior Brand Manager.

    What were the most satisfying aspects of your new Novartis ventures?  Getting involved in really broad campaigns was very exciting. With influenza it’s not just a case of painting patient pictures, you are convincing people to purchase products there and then; sign on the dotted line. From a marketing view, delivering an effective strategy is essential, but from a sales view, you’ve effectively got twenty minutes in front of a healthcare professional to deliver, not just a generic pitch, but one that demonstrates empathy, understanding and confidence in your proposition. There’s only one chance, so you have to make every interaction count.

    Does it make you appreciate the impact you’re having on society? It’s pretty amazing to think that last year the number of vaccines given through pharmacy alone could fill St. James’s Park. That really puts the number into perspective.

    Do you support Newcastle United, by any chance? Yes, I used to go with my dad, when David Ginola was playing (judging by the wistful expression, I think Caroline may have been a great admirer of the aforementioned Frenchman).

    I digress, what programmes are you putting into place in preparation for the dreaded reform act? We have been very passionate about implementing vaccination programmes, which enable a more community-based approach to health. We’re training pharmacists to vaccinate in local pharmacies, enabling many more thousands of people to access healthcare. It will certainly relieve some of the pressure from GPs. People will have the convenience of being able to pick up their weekly shop and a vaccine, all in one place.

    How do big companies react to changes enforced by new political policies? From an industry perspective you can’t plan too far in advance because you simply don’t know what the NHS will look like in a few years. If Labour get in all the changes might be reversed and we’ll end up going round in circles.

    You’re still young, but seem to have ascended up the ranks rapidly I enjoy what I do and like to do it well; then I’m ready for the next challenge. When you reach milestones in your career it’s so important that you have a story to tell, making sure that it’s as fulfilling and successful as it can be. Some people are satisfied to do the same thing for years, but I want each chapter to represent a new adventure and an opportunity to make a difference.

    What does the future hold for you? I’m starting a new job in Basel! (Caroline is making the pilgrimage to Switzerland and she’ll be working as Business Franchise Manager in Novatis’ Ophthalmology business unit – which is nice).

    That’ll be incredible Yes, I’m going there with my partner and it will certainly be a great experience. It’s a global role so it will be really interesting to see how other health services, like Australia and Canada, operate compare to ours. I hope they don’t have as many acronyms.

    There’ll also be some cultural differences in Switzerland too? Yep, for a start, they only serve wine in 100ml measures and that will take some getting used to!

    What will you miss? The higher your position, the greater potential there is for you to be removed from the ‘patient’.  I think I will miss the daily coal face interaction you get when you work in a local market, close to the actual health provision. That is why I think it is so important to remember what it is like when you are on the road, bringing products to life. Ultimately, whether you are in a local or a global role, everything you do is still for the patient.

    • TAGS
    • Altana Pharma
    • AmDel
    • Biomedical Science
    • Caroline Armstrong
    • coffee break
    • David Ginola
    • GP
    • health
    • healthcare
    • influenza
    • john pinching
    • Joint Working Award
    • Labour
    • medical sales
    • medical sales representative
    • Newcastle
    • Newcastle Upon Tyne University
    • NHS
    • Novartis
    • Novartis Ophthalmology Business Unit
    • pf
    • Pf Awards
    • pharmaceutical industry
    • pharmacists
    • Proctor and Gamble
    • St. James Park
    • Vaccine Account Manager
    Pharmafield
    Facebook
    Twitter
    Linkedin
    Email
      Previous articleAusterity threatens Europe’s disease prevention
      Next articleEaston: Private challenge ‘too good to miss’

      RELATED ARTICLESMORE FROM AUTHOR

      Talking heads - what can pharma learn from 2020?
      In Depth

      Talking heads – what can pharma learn from 2020?

      The future of clinical research
      In Depth

      The future of clinical research

      Bringing in change with Brexit
      In Depth

      Bringing in change with Brexit

      The cost of COVID-19 on lung cancer progress
      COVID-19

      The cost of COVID-19 on lung cancer progress

      How the NHS and pharma are working together to improve cancer services
      In Depth

      How the NHS and pharma are working together to improve cancer services

      In Depth

      The importance of adherence

      SUBSCRIBE

      Follow us


      Latest articles

      COVID-19 one year on - key changes

      COVID-19 and key changes one year on

      COVID-19 Oli Hudson - March 5, 2021
      One year on from the first confirmed case of COVID-19 in the UK, Oli Hudson, Content Director at Wilmington Healthcare, takes a look at...
      FDA approval for Roche’s Actemra/RoActemra in lung disease

      FDA approves Roche’s Actemra/RoActemra for interstitial lung disease

      Pharma News Emma Cooper - March 5, 2021
      Roche has announced that the U.S. Food and Drug Administration (FDA) has approved Actemra®/RoActemra® (tocilizumab) subcutaneous injection for slowing the rate of decline in...
      Pre-clinical work completed for novel COVID-19 immunotherapy

      Pre-clinical work completed for novel COVID-19 immunotherapy

      COVID-19 Emma Cooper - March 4, 2021
      ISA Pharmaceuticals has announced that it has completed pre-clinical work for ISA106, a novel COVID-19 immunotherapy and is planning clinical trials. A phase 1...

      Popular articles

      Image of a person descending a ladder over coronavirus to show New Normal, New Thinking: Life Post COVID-19

      New Normal, New Thinking: Life Post COVID-19

      COVID-19 Mark Pringle - June 1, 2020
      New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
      Image of a scientist at their lab to show Study shows existing anti-parasitic drug kills coronavirus within 48 hours

      Study shows anti-parasitic drug ivermectin kills coronavirus within 48 hours

      COVID-19 Amy Schofield - April 6, 2020
      A collaborative study led by the Monash Biomedicine Discovery Institute (BDI) with the Peter Doherty Institute of Infection and Immunity (Doherty Institute), a joint...
      NHS prescription charge to increase from 1st April

      NHS prescription charge to increase from 1 April 2021

      Pharma News Emma Cooper - February 25, 2021
      The NHS prescription charge will increase to £9.35 per prescription item from 1 April 2021 in England, according to the Pharmaceutical Services Negotiating Committee...
      Nasal spray to protect against COVID-19 is ready for use in humans

      Nasal spray to protect against COVID-19 is ready for use in humans

      COVID-19 Emma Cooper - November 19, 2020
      A nasal spray to provide protection against the COVID-19 virus has been formulated by researchers at the University of Birmingham, UK, using compounds already...

      Pancreatic Cancer Story: James Dadge

      Healthcare Emma Hedges - November 15, 2018
      James, 44, lives in Manchester with his partner Andrea and sons Ben and Daniel. He was diagnosed with a neuroendocrine tumour, with the primary...
      Pharma and healthcare news, features and events | Pharmaceutical jobs and career advice | Pharma opinion, analysis and thought leadership

      © Pharmafield all rights reserved . Pharmafield is part of the Events4Healthcare Group
      Contact us: hello@pharmafield.co.uk
      • Subscribe
      • About
      • Advertise
      • Submissions
      • Contact
      Terms & Conditions | Privacy Policy

      Subscribe

      Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

      Claim my free subscription

      This website uses cookies to improve your experience. By continuing to use this site we will assume you are ok with this. Read MoreAccept
      Edit with Live CSS
      Save
      Write CSS OR LESS and hit save. CTRL + SPACE for auto-complete.